[{"address1": "2430 North Halsted Street", "city": "Chicago", "state": "IL", "zip": "60614", "country": "United States", "phone": "847 673 1700", "fax": "847 556 6411", "website": "https://www.exicuretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  Kang", "age": 61, "title": "CEO, President & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jiyoung  Hwang", "age": 46, "title": "CFO, Secretary & Director", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Miller", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1730419200, "maxAge": 86400, "priceHint": 2, "previousClose": 17.25, "open": 17.75, "dayLow": 16.3999, "dayHigh": 18.4277, "regularMarketPreviousClose": 17.25, "regularMarketOpen": 17.75, "regularMarketDayLow": 16.3999, "regularMarketDayHigh": 18.4277, "beta": 1.283, "forwardPE": -22.83117, "volume": 126844, "regularMarketVolume": 126844, "averageVolume": 754661, "averageVolume10days": 89700, "averageDailyVolume10Day": 89700, "bid": 16.54, "ask": 18.18, "bidSize": 100, "askSize": 100, "marketCap": 53426148, "fiftyTwoWeekLow": 1.44, "fiftyTwoWeekHigh": 36.0, "priceToSalesTrailing12Months": 106.852295, "fiftyDayAverage": 11.4042, "twoHundredDayAverage": 4.643835, "currency": "USD", "enterpriseValue": 11804699, "floatShares": 771186, "sharesOutstanding": 3039030, "sharesShort": 31088, "sharesShortPriorMonth": 55848, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0143, "heldPercentInsiders": 0.4678, "heldPercentInstitutions": 0.04287, "shortRatio": 0.19, "shortPercentOfFloat": 0.0199, "impliedSharesOutstanding": 3039030, "bookValue": 1.752, "priceToBook": 10.034246, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -8172000, "trailingEps": -2.02, "forwardEps": -0.77, "lastSplitFactor": "1:5", "lastSplitDate": 1724803200, "enterpriseToRevenue": 23.609, "enterpriseToEbitda": -2.036, "52WeekChange": 4.9895835, "SandP52WeekChange": 0.2729931, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "XCUR", "underlyingSymbol": "XCUR", "shortName": "Exicure, Inc.", "longName": "Exicure, Inc.", "firstTradeDateEpochUtc": 1526995800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ee4bcb27-f318-38c7-8572-459785e7d845", "messageBoardId": "finmb_82271676", "gmtOffSetMilliseconds": -18000000, "currentPrice": 17.58, "recommendationKey": "none", "totalCash": 528000, "totalCashPerShare": 0.305, "ebitda": -5797000, "totalDebt": 7315000, "quickRatio": 0.317, "currentRatio": 0.606, "totalRevenue": 500000, "debtToEquity": 453.503, "revenuePerShare": 0.289, "returnOnAssets": -0.26405, "returnOnEquity": -1.44407, "freeCashflow": -2027500, "operatingCashflow": -3844000, "grossMargins": 1.0, "operatingMargins": -11.931999, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]